Ariel Barkan

1.1k total citations
22 papers, 487 citations indexed

About

Ariel Barkan is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Ariel Barkan has authored 22 papers receiving a total of 487 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Surgery and 3 papers in Molecular Biology. Recurrent topics in Ariel Barkan's work include Pituitary Gland Disorders and Treatments (10 papers), Growth Hormone and Insulin-like Growth Factors (7 papers) and Hormonal Regulation and Hypertension (3 papers). Ariel Barkan is often cited by papers focused on Pituitary Gland Disorders and Treatments (10 papers), Growth Hormone and Insulin-like Growth Factors (7 papers) and Hormonal Regulation and Hypertension (3 papers). Ariel Barkan collaborates with scholars based in United States, Israel and Italy. Ariel Barkan's co-authors include Шломо Мелмед, Vivien Bonert, Stephan Petersenn, Philippe Chanson, Mary Lee Vance, Anne Klibanski, David L. Kleinberg, David C. Rhew, David M. Cook and Jochen Schopohl and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

Ariel Barkan

19 papers receiving 467 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ariel Barkan United States 9 399 174 152 49 38 22 487
H Gerl Germany 12 268 0.7× 121 0.7× 63 0.4× 58 1.2× 35 0.9× 26 419
S. Ferasin Italy 11 349 0.9× 152 0.9× 74 0.5× 86 1.8× 40 1.1× 15 519
Susan E. Stewart United Kingdom 7 248 0.6× 99 0.6× 109 0.7× 35 0.7× 18 0.5× 7 339
Gaëlle Barrande France 9 348 0.9× 245 1.4× 47 0.3× 42 0.9× 17 0.4× 14 459
Ioanna Tzavara Greece 11 342 0.9× 183 1.1× 127 0.8× 25 0.5× 36 0.9× 16 458
Raluca Trifănescu Romania 9 364 0.9× 263 1.5× 70 0.5× 37 0.8× 16 0.4× 31 465
Rajeev Kasaliwal India 14 291 0.7× 169 1.0× 67 0.4× 25 0.5× 72 1.9× 23 434
Elena V Varlamov United States 14 522 1.3× 246 1.4× 100 0.7× 43 0.9× 27 0.7× 28 602
Márcio Carlos Machado Brazil 13 423 1.1× 210 1.2× 93 0.6× 44 0.9× 27 0.7× 30 512
Daniela Betea Belgium 12 321 0.8× 180 1.0× 146 1.0× 62 1.3× 161 4.2× 28 611

Countries citing papers authored by Ariel Barkan

Since Specialization
Citations

This map shows the geographic impact of Ariel Barkan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ariel Barkan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ariel Barkan more than expected).

Fields of papers citing papers by Ariel Barkan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ariel Barkan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ariel Barkan. The network helps show where Ariel Barkan may publish in the future.

Co-authorship network of co-authors of Ariel Barkan

This figure shows the co-authorship network connecting the top 25 collaborators of Ariel Barkan. A scholar is included among the top collaborators of Ariel Barkan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ariel Barkan. Ariel Barkan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Lacroix, André, Marcello D. Bronstein, Jochen Schopohl, et al.. (2020). Long-acting pasireotide improves clinical signs and quality of life in Cushing’s disease: results from a phase III study. Journal of Endocrinological Investigation. 43(11). 1613–1622. 15 indexed citations
3.
VanKoevering, Kyle K., et al.. (2019). Pituitary Dysfunction after Radiation for Anterior Skull Base Malignancies: Incidence and Screening. Journal of Neurological Surgery Part B Skull Base. 81(1). 75–81. 12 indexed citations
4.
VanKoevering, Kyle K., et al.. (2017). Pituitary Dysfunction after Radiation for Anterior Skull Base Malignancies: Incidence and Screening. Journal of Neurological Surgery Part B Skull Base. 78(S 01). S1–S156.
5.
Barkan, Ariel & Ronald J. Koenig. (2015). Clinical case seminar: unraveling the mystery of abnormal thyroid function tests. PubMed. 1(1). 14–14. 1 indexed citations
6.
Hochberg, Irit, Quynh T. Tran, Ariel Barkan, et al.. (2014). Gene expression signature in adipose tissue of acromegaly patients. BMC Bioinformatics. 15(S10). 2 indexed citations
7.
Wilson, Thomas S., Erin L. McKean, Ariel Barkan, William F. Chandler, & Stephen Sullivan. (2013). Repeat Endoscopic Transsphenoidal Surgery for Acromegaly: Remission and Complications. Journal of Neurological Surgery Part B Skull Base. 74(S 01). 3 indexed citations
8.
Petersenn, Stephan, Jochen Schopohl, Ariel Barkan, et al.. (2010). Pasireotide (SOM230) Demonstrates Efficacy and Safety in Patients with Acromegaly: A Randomized, Multicenter, Phase II Trial. The Journal of Clinical Endocrinology & Metabolism. 95(6). 2781–2789. 157 indexed citations
9.
Bonert, Vivien, Laurence Kennedy, Stephan Petersenn, et al.. (2008). Lipodystrophy in Patients with Acromegaly Receiving Pegvisomant. The Journal of Clinical Endocrinology & Metabolism. 93(9). 3515–3518. 52 indexed citations
10.
Мелмед, Шломо, David M. Cook, Anne Klibanski, et al.. (2005). A Critical Analysis of Pituitary Tumor Shrinkage during Primary Medical Therapy in Acromegaly. The Journal of Clinical Endocrinology & Metabolism. 90(7). 4405–4410. 164 indexed citations
11.
Barkan, Ariel & Patricia A. Wren. (2001). Authors’ Response: The QoL-AGHDA Questionnaire—Can it Be Used to Assess Quality of Life in Hypopituitarism?. The Journal of Clinical Endocrinology & Metabolism. 86(12). 5997–5997. 1 indexed citations
12.
Barkan, Ariel. (1995). Treating acromegaly: 100 years on. Trends in Endocrinology and Metabolism. 6(3). 106–107. 5 indexed citations
13.
Barkan, Ariel, et al.. (1982). Calcification of Auricular Cartilages in Patients with Hypopituitarism. The Journal of Clinical Endocrinology & Metabolism. 55(2). 354–357. 25 indexed citations
14.
Barkan, Ariel, et al.. (1981). Pyrexia of unknown origin. Presenting sign of hypothalamic hypopituitarism. Postgraduate Medical Journal. 57(667). 310–313. 2 indexed citations
15.
Barkan, Ariel, et al.. (1981). Hypercalcemia in carcinoma of the breast without evidence of bone destruction: Beneficial effect of hormonal therapy. Cancer. 48(11). 2383–2385. 13 indexed citations
16.
Barkan, Ariel, et al.. (1980). Primary Hyperparathyroidism: Possible Cause of Primary Hyperaldosteronism in a 60-Year-Old Woman*. The Journal of Clinical Endocrinology & Metabolism. 51(1). 144–147. 20 indexed citations
17.
Blum, I, Ariel Barkan, & Daniel Yeshurun. (1980). Thyrotoxicosis presenting as orthostatic hypotension. Postgraduate Medical Journal. 56(656). 425–426. 2 indexed citations
18.
19.
Blum, I, et al.. (1980). Case Report: Cardiac denervation and other multisystem manifestations caused by isolated autonomic neuropathy in a young diabetic patient. The American Journal of the Medical Sciences. 280(2). 87–92. 1 indexed citations
20.
Barkan, Ariel, et al.. (1980). Effect of Tumor Removal on the Presence of Lymphocytic Cortisol Metabolism-Enhancing Factor in Plasma of Cancer Patients23. JNCI Journal of the National Cancer Institute. 64(6). 1333–1335. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H Gerl Breakdown of academic impact, for papers by S. Ferasin Breakdown of academic impact, for papers by Susan E. Stewart Breakdown of academic impact, for papers by Gaëlle Barrande Breakdown of academic impact, for papers by Ioanna Tzavara Breakdown of academic impact, for papers by Raluca Trifănescu Breakdown of academic impact, for papers by Rajeev Kasaliwal Breakdown of academic impact, for papers by Elena V Varlamov Breakdown of academic impact, for papers by Márcio Carlos Machado Breakdown of academic impact, for papers by Daniela Betea
Rankless by CCL
2026